ClinicalTrials.govpublic full text
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
nsclc, non-small cell lung cancer, lung cancer, non-small cell lung cancer stage i, non-small cell lung cancer stage ii, non-small cell lung cancer stage iii, non-small cell lung cancer stage iiia, pd-l1 gene mutation, durvalumab, early stage nsclc, 20-145, memorial sloan kettering cancer center
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 893133
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.